-
Document de presse | 2018.04.10
Hepatitis C: a novel point-of-care assay
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques that can be "decentralized", in other words accessed by populations and countries with limited resources. Scientists from the Institut Pasteur and Inserm, in collaboration...
-
News | 2018.05.22
Tiger mosquitoes: heightened surveillance in France, from May to November 2018
On Monday April 30, 2018, the French Ministry of Health announced that it was stepping up surveillance of the tiger mosquito, Aedes albopictus, which is now present in 42 French départements – twice as many as two years ago. But just how dangerous is this mosquito, vector of diseases such as dengue, chikungunya or zika?The tiger mosquito (see What is the "tiger mosquito" (Aedes albopictus)?) is...
-
News | 2018.07.04
A modular gene enhancer plays a role in leukemia
Every day, the bone marrow generates billions of new blood cells. This process, known as hematopoiesis, consists of a series of stages by which hematopoietic stem cells produce red blood cells, macrophages, lymphocytes, etc. The MYC gene and the mechanisms that regulate its expression play a major role in these various stages, but they are also involved in several types of leukemia as a result of...
-
News | 2020.04.30
A comprehensive analysis of midbodies, bridges between dividing cells
Scientists at the Institut Pasteur have developed a method to isolate midbodies, bridges that link cells undergoing cytokinesis. Using the latest mass spectrometry methods, they produced a comprehensive inventory and revealed the presence of 1,732 proteins! By characterizing three of these proteins in detail, they pinpointed novel molecular mechanisms involved in both cell division and virus...
-
News | 2022.12.01
Institut Pasteur at the 2022 Utopiales international science fiction festival in Nantes
For the second year in a row, the Institut Pasteur was one of the official scientific partners of the Utopiales festival, which took place from October 29 to November 1 at La Cité Nantes Congress Center.
-
Document de presse | 2023.12.06
Plasmodium vivax malaria: infections may be largely underestimated in sub-Saharan Africa
Researchers from the Institut de Parasitologie et de Pathologie Tropicale at the University of Strasbourg and the Laboratoire de Parasitologie et de Mycologie Médicale at the Strasbourg University Hospital, in collaboration with King's College London, UK, the Institut Pasteur (Paris, France), the Institut Pasteur de Madagascar and the University of Addis Ababa, Ethiopia, have revealed how...
-
News | 2024.03.19
Pasteur Museum: transferring the collections to protect them
As part of the work to restore and renovate the Institut Pasteur's historical building, the Pasteur Museum recently embarked on an unprecedented process to transfer its collections. This involves meticulously preparing the items so that they can be stored in dedicated spaces that are suitable for housing such valuable objects.
-
News | 2023.05.12
A new approach to developing mouse 'embryos' in vitro
The study of embryonic development is a complex and tightly regulated field. By influencing a process that regulates gene expression, researchers at the Institut Pasteur have succeeded in recreating in vitro mouse cell clusters that mimic in some respects the structure of real embryos. By avoiding the manipulation of embryos, these approaches pave the way for applications such as the study of...
-
Fiche maladie | 2024.08.23
Stomach cancer and gastric ulcers
The bacterium Helicobacter pylori (H. Pylori) is the causative agent of stomach diseases in humans, including chronic gastritis, gastric ulcers (open sores that develop on the mucosa lining the stomach) and duodenal ulcers. It also plays a major role in stomach cancer genesis (adenocarcinoma and lymphoma). These findings have led to a review of treatment for peptic ulcer disease which is now...
-
Article | 2020.08.13
The Institut Pasteur Innovation Accelerator
The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...